Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approach-Reference-Cited by-同舟云学术

Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approach

Published:2021-03-08 Issue: Volume: Page:1-22
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Kakarala Kavita Kumari¹,Jamil Kaiser¹

Affiliation:

1. Bhagwan Mahavir Medical Research Center, Hyderabad, Telangana, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2021.1891140

Reference123 articles.

1. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis

2. Allosteric inhibitors of Bcr-abl–dependent cell proliferation

3. Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives

4. Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications

5. Free Energy Via Molecular Simulation: Applications to Chemical and Biomolecular Systems

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages;PLOS ONE;2024-04-25

2. Network pharmacology integrated molecular docking of fucoidan against oral cancer and in vitro evaluation- A study using GEO datasets;Journal of Biomolecular Structure and Dynamics;2024-02-22

3. Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation Studies in Pancreatic Cancer;Current Computer-Aided Drug Design;2023-12

4. Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer;Bioorganic & Medicinal Chemistry;2023-08

5. Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review;Current Medicinal Chemistry;2022-12